CAROZZI, VALENTINA ALDA
 Distribuzione geografica
Continente #
NA - Nord America 19.716
AS - Asia 13.426
EU - Europa 9.392
SA - Sud America 1.540
Continente sconosciuto - Info sul continente non disponibili 1.192
AF - Africa 262
OC - Oceania 54
Totale 45.582
Nazione #
US - Stati Uniti d'America 18.580
SG - Singapore 4.429
CN - Cina 3.004
VN - Vietnam 2.454
IT - Italia 2.419
HK - Hong Kong 1.494
DE - Germania 1.324
RU - Federazione Russa 1.311
BR - Brasile 1.175
SE - Svezia 981
CA - Canada 935
IE - Irlanda 815
UA - Ucraina 643
GB - Regno Unito 529
FR - Francia 371
IN - India 358
KR - Corea 265
BD - Bangladesh 264
FI - Finlandia 243
ID - Indonesia 193
AT - Austria 153
JP - Giappone 151
TR - Turchia 146
AR - Argentina 139
NL - Olanda 120
IQ - Iraq 119
MX - Messico 106
ZA - Sudafrica 91
ES - Italia 90
PK - Pakistan 80
DK - Danimarca 72
PL - Polonia 71
SA - Arabia Saudita 63
PH - Filippine 59
LT - Lituania 58
MY - Malesia 56
CH - Svizzera 55
EC - Ecuador 50
CO - Colombia 45
BE - Belgio 43
VE - Venezuela 40
IR - Iran 37
AU - Australia 36
UZ - Uzbekistan 36
MA - Marocco 31
EG - Egitto 29
AE - Emirati Arabi Uniti 28
CL - Cile 28
PY - Paraguay 28
TN - Tunisia 25
KE - Kenya 21
TW - Taiwan 21
TH - Thailandia 20
ET - Etiopia 19
EU - Europa 19
NP - Nepal 19
JO - Giordania 18
JM - Giamaica 17
OM - Oman 17
AZ - Azerbaigian 16
HN - Honduras 16
NZ - Nuova Zelanda 16
RO - Romania 14
CR - Costa Rica 12
IL - Israele 12
BO - Bolivia 11
KZ - Kazakistan 11
PE - Perù 11
UY - Uruguay 11
NI - Nicaragua 10
PS - Palestinian Territory 10
CZ - Repubblica Ceca 9
DZ - Algeria 9
TT - Trinidad e Tobago 9
LB - Libano 8
AL - Albania 7
HU - Ungheria 7
NG - Nigeria 7
SV - El Salvador 7
BG - Bulgaria 6
BH - Bahrain 6
PR - Porto Rico 6
PT - Portogallo 6
RS - Serbia 6
AO - Angola 5
CI - Costa d'Avorio 5
KG - Kirghizistan 5
LV - Lettonia 5
MD - Moldavia 5
NO - Norvegia 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
GE - Georgia 4
GR - Grecia 4
HR - Croazia 4
KW - Kuwait 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
Totale 44.357
Città #
Singapore 2.696
Ann Arbor 2.214
Ashburn 1.533
Hong Kong 1.441
San Jose 1.368
Dallas 1.211
Milan 948
Woodbridge 902
Dublin 781
Ho Chi Minh City 732
Chandler 715
Houston 691
Frankfurt am Main 665
Toronto 648
Jacksonville 628
Hanoi 552
Fairfield 535
Dearborn 505
Wilmington 491
New York 475
Council Bluffs 467
Santa Clara 452
Beijing 384
Los Angeles 365
Hangzhou 344
Princeton 306
Chicago 292
The Dalles 267
Seattle 240
Boardman 238
Seoul 222
Hefei 220
Nanjing 203
Rome 171
Cambridge 166
Shanghai 166
Columbus 163
Lauterbourg 152
Buffalo 140
Jakarta 135
Vienna 131
São Paulo 103
Lachine 102
Guangzhou 101
Orem 101
Moscow 98
Helsinki 93
Altamura 92
Dong Ket 89
Lawrence 86
Da Nang 78
Munich 78
Haiphong 73
Nanchang 72
Tokyo 70
Phoenix 66
Shenyang 64
Brooklyn 63
London 58
Nuremberg 56
Baghdad 54
Denver 52
Warsaw 52
Andover 51
Chennai 50
Ha Long 48
Hải Dương 48
Changsha 46
Montreal 46
Atlanta 45
Rio de Janeiro 45
Biên Hòa 44
Vilnius 42
Zurich 42
Amsterdam 41
Jinan 41
Zhengzhou 41
Carate Brianza 40
Tianjin 40
Stockholm 39
Jiaxing 38
San Diego 38
Grafing 37
Johannesburg 37
San Francisco 37
Ottawa 36
Bắc Ninh 35
Pune 35
Fremont 34
Ninh Bình 34
Tashkent 34
Can Tho 33
Mexico City 33
Manchester 32
Quận Bình Thạnh 32
Turin 32
Hebei 31
Poplar 30
Boston 29
Brussels 29
Totale 28.081
Nome #
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 590
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 517
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 513
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 498
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 461
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 461
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 459
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 447
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 442
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 440
Age-related changes in the function and structure of the peripheral sensory pathway in mice 426
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 423
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 422
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 409
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 403
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 401
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 395
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 390
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 386
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 381
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 376
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 371
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 363
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 362
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 345
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 344
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 339
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 336
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 327
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 326
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 322
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 322
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 318
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 312
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 312
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 312
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 310
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 308
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 303
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 300
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 295
In vivo study of Carfilzomib-Induced Neuropathy 295
Expression, distribution and glutamate uptake activity of high affinity-excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 294
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 293
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 292
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 290
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 288
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 285
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 283
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 283
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 276
Effect of proteasome inhibition on the central and peripheral nervous system 275
Multimodal experimental approach to the study of human neurological diseases 273
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 272
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 271
MSCs effect on Dark Agouti rats affected by chronic EAE 271
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 268
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 268
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 266
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 264
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 264
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 263
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 262
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 261
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 259
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 259
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 259
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 257
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 256
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 256
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 254
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 252
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 252
Lipoplatin tm: a less neurotoxic formulation of cisplatin 252
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 251
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 251
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 250
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 249
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 249
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 248
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 247
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 246
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats 243
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 243
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 242
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 241
The relevance of morphology in experimental oxaliplatin-induced peripheral neurotoxicity 241
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 240
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 239
NOVEL HIGH-RESOLUTION-APPROACHES TO STUDY THE VASCULAR NETWORKS IN THE PERIPHERAL NERVOUS SYSTEM OF RATS WITH CISPLATIN-INDUCED PERIPHERAL NEUROTOXICITY 238
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 237
Focus on the role of Glutamate in the pathology of the peripheral nervous system 235
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 233
Correlation between organic cation transporter expression in rat dorsal root ganglia neurons and cisplatin-induced peripheral neurotoxicity 229
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 228
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 228
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level 225
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 222
The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity 221
Cisplatin-induced painful peripheral neuropathy severity is strain-dipendent in mice: dissecting the role of pharmacogenomics. 220
Totale 30.876
Categoria #
all - tutte 140.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.598 0 165 121 158 144 195 68 91 70 127 113 346
2022/20233.151 383 826 330 271 203 507 56 162 275 34 64 40
2023/20242.645 95 76 100 112 326 657 458 128 170 67 49 407
2024/20256.915 394 844 609 318 543 275 443 222 785 856 562 1.064
2025/202619.017 2.397 1.566 1.993 1.514 1.652 1.021 2.486 967 1.452 1.528 1.185 1.256
2026/20271.388 719 669 0 0 0 0 0 0 0 0 0 0
Totale 45.582